NEWSBRIEF: Gene Logic Reports Widened Revenue, Narrowed Loss, Contracted R&D in Q1

Apr 29, 2002

NEW YORK, April 29 - Gene Logic today reported wider revenue and a narrower first-quarter loss as it racked up more pharma and biotech subscribers.

Revenue for the period ended March 31 rose to $11.8 million from $8.2 million, and net loss narrowed to $7.5 million, or $.28 a share, from $10.6 million, or $.40 per share, one year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Dual Listings Sought

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

Allocating the Grant Pie

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

More Proposed for NSF

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

This Week in PNAS

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.

Main menu